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ABSTRACT
Direct targeting of critical DNA-binding elements of
a repressor by its cognate antirepressor is an effect-
ive means to sequester the repressor and remove a
transcription initiation block. Structural descriptions
for this, though often proposed for bacterial and
phage repressor–antirepressor systems, are un-
available. Here, we describe the structural and func-
tional basis of how the Myxococcus xanthus CarS
antirepressor recognizes and neutralizes its
cognate repressors to turn on a photo-inducible
promoter. CarA and CarH repress the carB operon
in the dark. CarS, produced in the light, physically
interacts with the MerR-type winged-helix DNA-
binding domain of these repressors leading to
activation of carB. The NMR structure of CarS1, a
functional CarS variant, reveals a five-stranded,
antiparallel b-sheet fold resembling SH3 domains,
protein–protein interaction modules prevalent in eu-
karyotes but rare in prokaryotes. NMR studies and
analysis of site-directed mutants in vivo and in vitro
unveil a solvent-exposed hydrophobic pocket lined
by acidic residues in CarS, where the CarA DNA rec-
ognition helix docks with high affinity in an atypical
ligand-recognition mode for SH3 domains. Our
findings uncover an unprecedented use of the SH3
domain-like fold for protein–protein recognition
whereby an antirepressor mimics operator DNA in
sequestering the repressor DNA recognition helix to
activate transcription.
INTRODUCTION
A classical mechanism for negative regulation of tran-
scription initiation is to sterically block promoter access
to RNA polymerase by a repressor bound at an operator
site that overlaps with promoter elements (1–3). This tran-
scription block is removed under appropriate conditions
by disrupting the operator–repressor complex in a variety
of ways, such as by the repressor binding to small
molecule inducers or to other protein factors—the
antirepressors (4). Non-covalent union to an antirepressor
can inactivate a repressor by altering its conformation,
oligomeric state, susceptibility to proteolysis or aggrega-
tion, or intracellular localization (5–9); or it may occlude
DNA-binding elements of the repressor (10). Structural
descriptions are available for how an antirepressor binds
to a repressor and alters the latter’s conformation,
oligomeric state or proteolytic susceptibility to thwart
operator-binding (5,6,9). By contrast, structural details
for the direct interaction of an antirepressor with a
speciﬁc, crucial DNA-binding repressor element have, to
our knowledge, not been reported, even though this mech-
anism of action has been proposed for many bacterial and
phage antirepressors. Here, we describe the structural
and functional basis of how the CarS antirepressor of
the bacterium Myxococcus xanthus recognizes and neu-
tralizes cognate repressors to turn on a photo-inducible
promoter.
Blue light induces carotenogenesis in M. xanthus, where
all but one of the structural genes involved are encoded by
the light-inducible carB operon (11). carB expression is
driven by promoter PB, and its photo-induction is
regulated by the CarA–CarS repressor–antirepressor pair
(12,13). In the dark, RNA polymerase access to PB is
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operator, of which one part overlaps with the  35
promoter region (14). Blue light causes expression of the
carQRS operon to produce CarS (11). Physical interaction
of CarS with CarA then dismantles the CarA–operator
complex to derepress PB. A parallel pathway for regula-
tion of PB also exists. It involves CarS and the CarH re-
pressor, which shares the two-domain architecture of
CarA. Both repressors have an N-terminal, MerR-type,
winged-helix DNA-binding domain that recognizes the
same operator as well as CarS, linked to a C-terminal di-
merization domain with a vitamin B12-binding motif
(10,15). However, only CarH requires B12 for repressor
activity (15).
The DNA recognition helix of CarA is crucial in
mediating interactions with both operator DNA and
CarS (10). Does CarS then have structural features that
resemble operator DNA? In this study, we demonstrate
that CarS adopts a fold characteristic of an SH3 (Src
homology 3) domain and that the CarA DNA recognition
helix is, by itself, suﬃcient for high-aﬃnity binding to
CarS. SH3 domains are protein–protein interaction
modules frequently encountered in proteins acting in
signal transduction, endocytic and cytoskeletal
machineries in eukaryotes, but which are much less
common in prokaryotes (16–18). The molecular details
of how CarS recognizes CarA diﬀer, however, from
those of typical SH3 domains. Our structural and func-
tional analyses reveal an apolar solvent-exposed pocket in
CarS, bordered by negatively charged residues, where the
CarA recognition helix can dock and, thereby, be
occluded from operator-binding. Thus, this work
provides structural–functional insights into an elegant mo-
lecular mechanism to turn on transcription, in which a
bacterial antirepressor with an SH3 domain fold mimics
operator DNA to sequester a repressor.
MATERIALS AND METHODS
Bacterial strains, plasmids and growth conditions
Supplementary Table S1 lists the M. xanthus strains and
plasmids used in this study. Myxococcus xanthus was
grown in casitone–Tris (CTT) rich medium with or
without blue light exposure (10). Escherichia coli strain
DH5a, used in plasmid constructions, and BL21(DE3),
employed for protein overexpression, were grown in
Luria broth or a modiﬁed M9 minimal medium containing
15NH4Cl with and without
13C-glucose to express
15N,
13C-labeled and
15N-labeled H6CarS1, respectively.
Site-directed mutagenesis
Speciﬁc mutations to Ala in CarS were generated by PCR
using the required construct containing wild-type carS as
template and two complementary primers bearing the
given mutation either by the overlap extension method
(19), or the Quikchange mutagenesis kit (Stratagene).
The presence of the desired mutation was conﬁrmed by
DNA sequencing.
Proteins and peptides
H6-tagged CarS, CarS1, CarANt and CarHNt were
overexpressed from constructs in pET15b, puriﬁed and
the H6-tag removed by thrombin cleavage as described
elsewhere (10,15). CarS variants, generated as described
above, were overexpressed using pET15b and puriﬁed
as described for CarS.
15N-labeled and
15N,
13C-labeled
H6CarS1 were overexpressed and puriﬁed as reported pre-
viously (20). Synthetic N-acetylated, C-amidated peptides
were purchased from Caslo Laboratory, Denmark.
Protein and peptide concentrations were determined
using the BioRad protein assay kit or the absorbance at
280nm. e280 (in M
 1cm
 1). Extinction coeﬃcients at
280nm used were (10,15): 9540 (CarANt); 6990 (CarS
and variants); 1490 (CarS1); 11460 (CarHNt); 6990
(P01, P02, CHP01, TtP01); 5500 (P03).
NMR
NMR data were acquired in Bruker DMX600 and
AV-800 US2 spectrometers equipped with a z-shielded
gradient triple resonance cryoprobe.
1H,
15N and
13C
NMR chemical shifts of CarS1 assigned using standard
triple resonance methods have been deposited in
BioMagResBank (ref. no. 15770; http://www.bmrb.wisc.
edu/; 20). Structures were calculated with the program
CYANA version 1.0 (21) using distance constraints from
NOE data (from
15N-edited and simultaneous
15N and
13C-edited NOESY HSQC data for  m=80ms), and
torsion angle constraints determined using TALOS (22).
The best structures from CYANA were reﬁned with the
SANDER module of the AMBER 7.0 package (23), and
analyzed using PROCHECK (24), VADAR (25) and
MOLMOL (26). Surface potential calculations with
MOLMOL used an ionic strength of 150mM and
default values for the dielectric constants of solute and
solvent. Amide
1H exchange data were obtained at 25 C
by adding 100% D2Ot o
1H-
15NH 6CarS1 lyophilized in
100mM NaCl, 50mM phosphate buﬀer (pH 6.6), and re-
cording
1H-
15N HSQC spectra consecutively every 45 min.
Peak intensities were ﬁt to a single exponential decay to
determine the exchange rate constants, and thereby
protein stability parameters (27). Heteronuclear
1H-
15N
NOEs were determined using
15N-labeled H6CarS1 at
25 C, pH 6.6, with
1H saturation (3s pulse applied just
prior to the ﬁrst heteronuclear pulse) during the prepar-
ation time with or without NOE. The pulse sequence
began with direct
15N excitation and subsequent magnet-
ization transfer using INEPT (28) to the corresponding
1H, with long waiting times between each pulse cycle for
complete relaxation. Heteronuclear
1H-
15N NOEs were
measured from the ratio of cross-peak intensities (using
SPARKY 3; Goddard, T.D., and Kneller, D.G., San
Francisco, University of California) with and without
1H saturation. NMR chemical shift mapping was carried
out at 25 Co r4 5  C by titrating
15N,
13C-H6CarS1 at
0.10–0.25mM with 0.25, 0.50, 0.75, 1.0, 1.5, 2.0 and 4.0
equivalents of unlabeled CarANt or peptides P01 or P02,
and recording
1H-
15N and
1H-
13C HSQC spectra after
each addition. Chemical shift perturbations (d were
calculated from the shifts in the backbone amide
1H
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15N( dN) signals using
d ¼½ ð d
2
H+d
2
N=25Þ=2 
1=2 (29).
Yeast two-hybrid analysis
We have previously described the constructs pEG202-
carA to express N-terminal fusions of CarA to the LexA
DNA-binding domain, and pJG4-5-carS for CarS fusions
to the B42 transcriptional activation domain (12). Each
carS variant, carS* (generated as described above) was
also cloned into pJG4-5 (Supplementary Table S1). The
recipient EGY48 yeast strain bearing the reporter plasmid
pSH18-34 was transformed by the lithium acetate method
with pEG202-carA and carS or carS* in pJG4-5. Ten
microliters from cultures of equal cell densities were
spotted on galactose (Gal) or glucose (Glu) plates supple-
mented with leucine, incubated for 1day at 30 C, then
overlaid with X-Gal
(5-bromo-4-chloro-3-indolyl-beta-D-galacto pyranoside)
agarose and incubated for a further 2–3h (Gal) or  7h
(Glu). CarA–CarS interaction was assessed from the blue
color that developed on plates.
Myxococcus xanthus strain construction and western
blot analysis
Plasmid pMR3184 (Supplementary Table S1) contains an
in-frame deletion of essentially all of the carS coding
sequence (327 out of 336bp). The deleted allele consists
of the ﬁrst 4bp of carS (as they include the TGA stop
codon of carR) separated from its last 5bp by an EcoRI
site. When expressed and translated in M. xanthus, this
deleted allele would render a four-residue peptide with
the sequence MRIQ. To construct pMR3184, regions
ﬂanking the carS region to be deleted were ﬁrst
PCR-ampliﬁed from genomic DNA: (i) an upstream
DNA fragment of  1.2kb with a 50 KpnI site and a
30 EcoRI site; (ii) a downstream DNA fragment of
 1kb with a 50 EcoRI site and a 30 PstI site. The two
fragments were ligated at the EcoRI site and then
introduced into the KpnI–PstI sites of plasmid
pMAR975. pMR3184, which also bears a kanamycin
(Km) resistance marker for positive selection and a Gal
sensitivity gene for negative selection, was then
electroporated into the wild-type DK1050 M. xanthus
strain, where plasmid integration into the chromosome
by homologous recombination yields Km
R merodiploids
containing the wild-type as well as the deleted carS
(carS) allele. To obtain a haploid strain bearing the
carS allele alone, a merodiploid was grown for several
generations in the absence of Km, and then plated on CTT
plates with 10mg/ml Gal to select for the loss of the vector
Gal
S marker together with one of the carS alleles by intra-
molecular recombination events. Haploid colonies with
the carS allele, easily identiﬁed by their inability to
turn red from yellow in blue light (Car
  phenotype),
were veriﬁed for the presence of the deletion by PCR
analysis of the corresponding chromosomal DNA region.
To introduce a mutant carS allele into M. xanthus,a
PCR-ampliﬁed fragment corresponding to the carS coding
sequence (without the initiator codon) bearing the speciﬁc
mutation (carS*) was ligated into the EcoRI site of
pMR3184. As a result of the construction, the CarS*
protein expressed once introduced into M. xanthus
would have, besides the mutation, an additional
three-residue, N-terminal sequence (R-I-L) separating
the initiator M from the I that is the second residue in
native CarS. A plasmid with wild-type carS (without the
initiator codon) introduced at the EcoRI site of pMR3184
was also generated for use as a positive control. The re-
sulting constructs (Supplementary Table S1) were inde-
pendently electroporated into the M. xanthus carS
strain MR1776 and plasmid integration into the chromo-
some by homologous recombination was selected for on
CTT/Km plates. Km
R colonies would be Car
+ (yellow in
the dark, red in the light) or Car
  (yellow in the dark and
in the light, like the carS strain) depending on whether
the incoming carS allele retains or lacks CarS activity. To
assay the color phenotypes, 8-ml cell droplets of exponen-
tially growing cultures (OD550=0.8) were spotted on
CTT plates and grown for 2days in the dark or in the
light. The absence of CarS in the carS strain
(MR1776) and the stable in vivo expression of each CarS
variant in the respective M. xanthus strain were conﬁrmed
by western blot analysis of the corresponding whole cell
extracts (obtained after cell growth in the light) with
mouse monoclonal anti-CarS antibodies. The total
protein concentrations of the extracts were estimated
and equivalent amounts of protein were loaded for
analysis. Antibody production and immunoblot analysis
of whole cell extracts were carried out as described previ-
ously (30).
CD spectroscopy
Far-UV CD spectra were recorded in an Applied
Photophysics (UK) Pistar apparatus coupled to a Peltier
temperature control device and a Neslab RTE-70 water
bath, and calibrated with (+)-10-camphorsulfonic acid.
Data were collected in 0.2-nm steps in the adaptive
sampling mode at 25 C with 10–20mM protein, peptides,
or 1:1 mixtures in 100mM KF, 7.5mM phosphate buﬀer
(pH 7.5), 1mM path length, 2-nm slit width and averaged
over three scans.
Calorimetry
Isothermal titration calorimetry (ITC) was carried out in a
MicroCal (Northampton, MA) VP-ITC system. Protein
samples were dialyzed against ITC buﬀer (100mM
NaCl, 50mM phosphate buﬀer pH 7.5, 2mM
b-mercaptoethanol, 0.05% sodium azide). Peptides were
dissolved in the ITC buﬀer. All samples were degassed
prior to ITC, and at least two independent titrations
were carried out for each condition. An amount of
1.44ml of 20mM CarANt or peptide in the ITC cell was
titrated with 30 injections of 8ml of 0.22mM CarS, CarS1,
or CarS* at a given temperature with stirring at 300rpm.
Control titrations with buﬀer alone in the ITC cell or the
injector syringe were used to correct for the heat of
dilution of the titrant. The average heat of the ﬁnal four
or ﬁve values in a titration with peptide solutions was used
to correct for the heat changes on mixing due to any slight
diﬀerences in the pH between the two solutions. Corrected
5228 Nucleic Acids Research, 2010,Vol.38, No. 15data were ﬁt to a single-site binding model using the
MicroCal Origin software to determine the binding stoi-
chiometry (N), binding enthalpy (H) and entropy (S),
and equilibrium association constants (Ka).
Analytical gel ﬁltration and EMSA
CarS, CarS1, or CarS* complex formation with CarNt or
CarHNt was analyzed in vitro using a Superdex200 ana-
lytical size-exclusion HPLC column. The column was
equilibrated with 50mM phosphate buﬀer (pH 7.5) con-
taining 2mM b-mercaptoethanol and the required NaCl
concentration. The calibration curve [obtained as in (10),
and essentially the same at 0.15M and 1.0M NaCl] was
log Mr=7.64–0.209Ve, where Mr is the apparent mo-
lecular weight and Ve, the elution volume. One
hundred-microliter samples of 10–50mM pure protein or
mixtures of CarNt or CarHNt, and CarS or CarS* at
equivalent concentrations were eluted at a ﬂow rate of
0.4ml/min and tracked by absorbances at 280, 235 and
220nm. Each peak fraction was collected, protein
identities were veriﬁed by SDS–PAGE, and Mr was
estimated from the corresponding Ve.
EMSA (electrophoretic mobility shift assays) were
carried out using a PCR-ampliﬁed, 130-bp DNA probe
containing the CarA operator and PB promoter, which
was
32P-labeled at the 50-end as described elsewhere (12).
A 20-ml reaction volume containing the DNA probe
(1.2nM,  13000 cpm), CarANt with or without CarS
or CarS* (ﬁnal concentrations as indicated), 100mM
KCl, 25mM Tris, pH 8, 1mM dithiothreitol, 10%
glycerol, 200ng/ml bovine serum albumin and 1mgo f
sheared salmon sperm DNA as non-speciﬁc competitor
was incubated at 37 C for 30min. Samples were
electrophoresed for 1–1.5h at 200V, 10 Ci na n8 %
non-denaturing polyacrylamide gel (37.5:1 acryl-
amide:bisacrylamide) that was pre-run for 30min in
0.5  TBE buﬀer (45mM Tris base, 45mM boric acid,
1mM EDTA). Gels were vacuum-dried and analyzed by
autoradiography. Band intensities were estimated using a
Gel Logic200 Imaging System and Kodak 1D
ImageAnalysis Software V3.6.
Docking using HADDOCK
Starting with the average energy-minimized NMR struc-
tures determined for the free proteins, CarANt was
docked onto CarS1 using the high-ambiguity-driven
protein–protein docking program HADDOCK (31).
Experimentally derived data from chemical shift perturb-
ations and site-directed mutagenesis (this study; 10) were
translated into the ambiguous interaction restraints for the
docking. Surface accessible residues (ASA 25%) deﬁned
as ‘active’ included: T34, D52, D53, L75, F77 and E79 in
CarS1; R10, R20, E23, R24, R25 and L32 in CarANt. The
neighbouring ‘passive’ residues were: S30, E31, I35, P54
and Q57 in CarS1; R6, M11, E16 and Y26 in CarANt.
Residues 48–65 and 73–82 in CarS1, and 2–12, 15–28 and
32–43 in CarANt were treated as semi-ﬂexible. The
docking involved randomization and rigid body energy
minimization, semi-ﬂexible simulated annealing and
ﬂexible explicit solvent reﬁnement to minimize structural
changes during docking. Of the initial 200 rigid-body
docked structures generated, the best 20 were reﬁned
ﬁrst by semi-ﬂexible simulated annealing, then in water
solvent, and clustered using a 3.0A ˚ RMSD cut-oﬀ
criteria. The resulting 20 complex models presented essen-
tially the same structure. The complex with the lowest
energy was selected as the most representative and
submitted to molecular dynamics reﬁnement with
AMBER (23). The complex structure with  5000 water
molecules was submitted to a standard equilibration
protocol described previously (32), and then to a long
run of 1ns of an unconstrained molecular dynamics cal-
culation using the AMBER-98 force ﬁeld (33) for the
solute, the TIP3P model to simulate water molecules
(34), and the Particle mesh Ewald method to evaluate
long-range electrostatic interactions (35). The last 25ps
of the trajectory were averaged and the resulting structure
was analyzed using MOLMOL (26).
RESULTS
Solution structure of CarS1 reveals a fold resembling
SH3 domains
CarS1 is a functional, truncated form of CarS (lacking
the last 25 residues) that, like CarS, forms a 1:1 complex
with the CarA or CarH N-terminal domain (10,15,36).
Given its excellent spectral dispersion and overall
quality, NMR studies were carried out with CarS1.
1H,
15N and
13C resonances were assigned using standard
triple resonance methods (20). The ensemble of the 20
lowest-energy structures calculated using experimental
constraints (Supplementary Table S2) revealed a dis-
ordered nine-residue N-terminal segment, a relatively
well-deﬁned loop with two arms (residues 10–13 and
17–19) in extended conformations, a 310 helix (residues
37–39) and a ﬁve-stranded b-sheet (Figure 1A
and Supplementary Figure S1). The b3–b4 hairpin is or-
thogonal to the b5–b1–b2 sheet, and long loops connect
b1t ob2 and b2t ob3. Pairwise root mean square devi-
ations (rmsd) for the superposition of the ﬁnal structures,
excluding the disordered, nine-residue N-terminal
segment, were 0.8±0.1A ˚ and 1.4±0.3A ˚ for the
backbone and heavy atoms, respectively (Supplementary
Table S2). Steady-state, backbone
15N-{
1H} heteronuclear
NOEs of  0.65 for several non-P residues in the b1–b2
loop suggest ﬂexibility with large amplitude motions on
the subnanosecond timescale (Supplementary Figure
S1C). Twenty-ﬁve residues mostly in strands b1t ob5
and involved in H-bonds showed the slowest amide
1H
exchange with solvent (three to four orders of magnitude
slower than random-coil values; Supplementary Figure
S1A). The total solvent-accessible surface area (ASA) in
native CarS1 is 6360A ˚ 2, and its hydrophobic core is
composed of 13 non-polar residues. Of the eight P in
CarS1, only P59 is in the cis form and is stabilized by
stacking interactions with Y58. With nine D and seven
E but only two each of R, K and H, CarS1 is highly
acidic (theoretical pI=4.1). Basic residues lie on one
face of the protein surface, while regions of high
negative electrostatic potential are on two other adjoining
Nucleic Acids Research, 2010,Vol.38, No. 15 5229Figure 1. CarS1 structure and interactions with CarANt from NMR. (A) Superposition of the backbone traces for the 20 ﬁnal NMR structures (left)
and ribbon diagram of the average structure. (B)C a-based overlay of the Abl tyrosine kinase SH3 domain (blue; PDB ID: 1JU5), R67-plasmid
DHFR (yellow; PDB ID: 1VIE), or chloroplast FTR subunit B (green; PDB ID: 1DJ7) onto CarS1 (red). The respective DALI Z-score/rmsd (A ˚ )/
sequence identity (%)/number of superimposed residues are: Abl SH3 domain: 3.4/2.6/6/50; DHFR: 5/1.6/20/49; FTR B: 5.2/2.7/21/57. Below is a
structure-based sequence alignment showing secondary structural elements and the RT, n-Src and distal (D) loops as denoted in SH3 domains.
Residues are shaded black if identical in at least two sequences and gray if similar. (C) Portion of the
1H-
13C HSQC spectrum of
13C,
15N-labeled
H6CarS1 (0.24mM) showing methyl crosspeaks perturbed by a 1.5-fold excess of unlabeled CarANt (red) compared to no CarANt added (black).
Inset shows negligible perturbation of labeled Ala methyl crosspeaks for comparison. (D) Ribbon and electrostatic surface models of CarS1 showing
residues that interact with CarANt from NMR data. Interacting side chains are depicted as magenta sticks with neighbouring acidic residues in red in
the ribbon model.
5230 Nucleic Acids Research, 2010,Vol.38, No. 15faces (Supplementary Figure S1D). These latter are likely
regions for interaction with CarANt, the highly basic and
autonomously folded N-terminal DNA-binding domain
of CarA.
A DALI search of the structure database (37) matched
the ﬁve-stranded b-sheet in CarS1 to the characteristic
fold of SH3 domains, small and diverse protein–protein
interaction modules typically involved in signal transduc-
tion pathways. The best matches (Z-scores 5) of CarS1,
a monomer, were to the bacterial R67-plasmid
dihydrofolate reductase (DHFR), which exists as
homodimers or tetramers (38), and to subunit B of the
chloroplast ferredoxin thioredoxin reductase (FTR)
heterodimer (39). Figure 1B shows an overlay of the
CarS1 b-sheet backbone onto DHFR, the FTR subunit
B, or the prototypal Abl tyrosine kinase SH3 domain and
the corresponding structure-based sequence alignment.
The CarS1 backbone fold diﬀers from the prototypal
SH3 domain fold primarily in the length of the ‘n-Src’
loop, in having a 310 helix between b2 and b3 rather
than between b4 and b5, and in the presence of an add-
itional N-terminal loop.
CarS1 residues contacting CarA mapped by NMR
CarS1 residues that contact CarA can be inferred from
NMR chemical shift perturbations on titrating
15N,
13C-labeled H6CarS1 with unlabeled CarANt. However,
in such titrations at 25 C, exchange-broadening eﬀects
caused disappearance of the
1H-
15N and
1H-
13C HSQC
crosspeaks. Similar problems on titrating
1H,
15N-labeled CarANt with unlabeled CarS1 were partly
alleviated by using higher temperature (45 C) and
adding 50mM arginine and glutamate in the buﬀer for
improved solubility (10). While these conditions also
reduced exchange broadening in titrations of
13C,
15N-labeled H6CarS1 with unlabeled CarANt, we
could not unambiguously assign the perturbed
1H-
15N
peaks. Nonetheless,
1H-
13C HSQC spectra indicated sig-
niﬁcant perturbations for the methyl cross-peaks of V26,
L63, L75, L81 (Figure 1C) and I64. Of these, only L63 and
L75 are suﬃciently solvent-exposed (ASA: 15 and 32%,
respectively; others <1%) to likely be part of a contact
surface. Since L63 is in the proximity of the
solvent-exposed F77 (ASA=34%; Figure 1D), any inter-
action with CarANt involving F77 that reorients its
aromatic side-chain could also perturb the L63 methyl
crosspeaks. Thus, NMR mapping suggests that L63, L75
and, possibly, F77 in CarS1 may interact with CarA.
CarS-binding surface probed by site-directed mutagenesis
To assess the functional importance of CarA-interacting
residues of CarS inferred from NMR, we examined the
consequences of mutating L63, L75, or F77 to A. The
role of the acidic residues in CarS was also assessed, as
some of these could be important in the interaction with
CarA, given that mutating the basic residues R24 and R25
in the latter abolished binding to CarS (10). Moreover,
E31, D32, D52, D53, E79 and E80 lie in the vicinity of
L63, L75 and F77 in CarS, hinting that some or all of
these may be involved in contacts with CarA
(Figure 1D). We therefore examined the consequences of
mutating these, as well as other acidic residues, in CarS.
Speciﬁcally, we generated single mutations to A of D4,
E69, E82 and E86; or double mutations to A of
D12/D14, E31/D32, D52/D53, D60/D61, E73/D74 and
E79/E80.
First, we monitored the eﬀects of these CarS mutations
on interactions with CarA by yeast two-hybrid analysis. In
the system employed, the LexA DNA-binding domain
fused to the N-terminus of CarA (LexA–CarA) served as
‘bait’, and CarS or any of its mutant forms (CarS*) fused
to the C-terminus of the B42 transcriptional activation
domain as ‘prey’. The B42–CarS hybrids were thus ex-
pressed from the GAL1 promoter, which is strongly
activated by galactose and repressed by glucose. Physical
interaction activates the reporter lacZ gene supplied in the
yeast host employed. Control cells producing only one
hybrid protein remained white on galactose plates even
24h after the X-gal overlay. By contrast, cells producing
LexA–CarA and B42–CarS turned blue within two hours,
as also did cells expressing LexA–CarA and the other
B42–CarS* fusions (Supplementary Figure S2A). Hence,
under these conditions, no diﬀerences in interactions with
CarA could be discerned between wild-type and any of the
CarS* forms. However, on glucose plates, where the
B42-fusions are expressed at basal levels, relative to the
blue color of cells expressing LexA–CarA and B42–CarS,
those expressing LexA–CarA and B42 fusions to the
D52A/D53A, E79A/E80A, L63A, L75A or F77A CarS*
were either white (like the negative control) or a very pale
blue even after a prolonged (7–24h) incubation with X-gal
(Figure 2A). These CarS* are thus likely to be impaired in
interactions with CarA. If this were indeed the case,
introducing these mutations in M. xanthus could result
in loss of light-induced carotenogenesis. Hence, this was
examined next.
We ﬁrst generated a carS strain bearing an in-frame
deletion of carS as described in ‘Materials and Methods’
section. Wild-type M. xanthus cells are yellow in the dark
and turn a deep red in the light due to photo-induced
carotenogenesis (Car
+ phenotype), whereas the carS
strain remains yellow even in the light (Car
 ) because
there is no CarS to derepress carB. We then introduced
into the carS strain a carS* allele (or wild-type carS as a
positive control), and then checked for rescue or otherwise
of the Car
+ phenotype. Western blots using monoclonal
anti-CarS antibodies of the corresponding whole-cell
extracts obtained after growth in the light conﬁrmed
stable expression of each CarS* in vivo (Supplementary
Figure S2B). In contrast to cells expressing wild-type
CarS, those producing the L63A, L75A, F77A, D52A/
D53A or E79A/E80A CarS* were Car
 , like the carS
strain (Figure 2B). The inability to restore the Car
+
phenotype thus accords with impaired interaction of
these CarS* with CarA inferred from two-hybrid analysis.
F77A and D52A/D53A CarS* were chosen as represen-
tative of non-polar and charged residues, respectively,
whose mutation aﬀected interactions with CarA. These
were analyzed in vitro using analytical gel ﬁltration, ITC
and EMSA. Pure CarS and the two variants eluted oﬀ a
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15.1±0.8kDa, compared to calculated monomer values
of around 12.5kDa; Mr is 9.6kDa for pure CarANt,
whose calculated value is 9.5kDa (Figure 2C). When
mixed with CarANt, CarS formed a stable 1:1 complex
eluting at Mr of 30±2kDa, and no free CarANt
peak was detected under the conditions used. In the
presence of CarANt, either CarS variant produced
a peak with Mr of 20.9±0.3kDa, considerably lower
than for the CarA–CarS complex, and the free CarANt
peak persisted at signiﬁcant levels (Figure 2C). Thus, con-
sistent with in vivo data, F77A and D52A/D53A CarS*
form less tight complexes with CarANt. This was also
conﬁrmed by ITC data: CarANt formed a 1:1, high
aﬃnity (the dissociation constant, KD=12nM) complex
with wild-type CarS, but its binding to the two CarS
variants could not be detected under similar conditions
(Table 1).
Figure 2. CarS residues interacting with CarA identiﬁed by site-directed mutagenesis. (A) Yeast two-hybrid analysis of the interactions of each CarS
mutant (CarS*) with CarA on glucose plates. C+: LexA–CarA and B42–CarS; C : LexA–CarA only; others: LexA–CarA and the indicated B42–
CarS*. (B) Color phenotypes for carotenogenesis in M. xanthus strains bearing the indicated carS allele. C+: wild-type; C : carS; others are
derived from introducing the indicated allele into the carS strain. (C) Elution proﬁles oﬀ a Superdex-200 analytical gel ﬁltration column for the
pure proteins (bottom) and CarANt mixed with CarS or CarS* (top). Dashed line is for pure CarANt; black, blue and red lines are for CarS, CarS*
(F77A) and CarS* (D52A/D53A), respectively, with or without CarANt. Mr (in kDa) for each peak maximum is shown. (D) Top: schematic of the
130-bp EMSA probe spanning the carB promoter region, relative to the transcription start site (+1). The operator pI (–64 to  47) and pII ( 40 to
 26) sites are shown with their palindromic halves boxed. Bottom: EMSA for CarANt-binding to the 130-bp probe alone (lanes 2–5) or with
increasing levels of CarS or CarS* added, as indicated.
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to favor CarA–operator binding. Hence, we also
compared the eﬀect of F77A or D52A/D53A CarS*
versus CarS on CarANt–operator binding in vitro using
EMSA. For this, we used a 130-bp DNA probe containing
both sites of the bipartite CarA operator: the high aﬃnity
pI site, located upstream of the promoter region, and the
low aﬃnity pII site that straddles the  35 promoter
element (Figure 2D). CarANt binds to this probe in a
step-wise manner, ﬁrst to each half-site of pI and then to
each half-site of pII, as is manifested by the progressive
appearance of a ladder-like pattern of retarded bands with
increasing CarANt amounts that gradually disappear as
excess CarS is added (lanes 1–8, Figure 2D). By contrast,
CarANt–operator complexes were disrupted neither by
F77A nor by D52A/D53A CarS* (lanes 9–14,
Figure 2D), consistent with their weaker interactions
with CarANt and their observed in vivo eﬀects on
light-induced carotenogenesis.
The CarA operator recognition helix is suﬃcient for tight
interaction with CarS
Two residues in the CarA DNA recognition helix a2 (R24,
R25) have been shown to be crucial in the interactions
with CarS, as noted earlier. Whether a2 alone can be
targeted by CarS was checked using synthetic peptides
that span CarA a2 (Figure 3A). P01 spans the a2
segment plus the subsequent eight C-terminal residues
containing two P reminiscent of P-rich domains
recognized by many SH3 domains (16,18); P02 corres-
ponds only to a2. Interactions of P01 and P02 with
CarS1 were probed by NMR, CD spectroscopy and ITC.
P01 or P02 produced signiﬁcant CarS1 chemical shift
perturbations demonstrating that they are suﬃcient
for interaction. Moreover,
1H-
13C HSQC methyl
crosspeaks of
13C,
15N-labeled H6CarS1 perturbed by
P01 or P02 matched those caused by CarANt (compare
Figure 3B with Figure 1C), suggesting that P01 and P02
maintain many of the same speciﬁc contacts as CarANt in
interacting with CarS1. In addition, we could identify sig-
niﬁcant perturbation of the P62 dCH and the E73 aCH
1H-
13C crosspeaks, and of a number of
1H-
15N HSQC
crosspeaks (Figure 3C) including those corresponding to
residues shown to be functionally important in the
previous section.
1Ha,
13Ca and
13Cb chemical shift devi-
ations from random coil values and medium range NOEs
characteristic of helical conformation observed for the free
peptides at 5 C suggest an intrinsic helical propensity in
the stretch equivalent to the CarANt a2 segment
(Supplementary Figure S3).
1Ha deviations were,
however, smaller than for the same residues in native
CarANt, especially at 25 C. This is consistent with lower
peptide helix content, as was conﬁrmed by the far-UV CD
spectra of the isolated peptides. By comparison, the helix
content (directly related to  [y]222, the molar residue el-
lipticity at 222nm in degrees cm
2 dmol
 1) of P01 is
markedly enhanced by the presence of a molar equivalent
of CarS1 (red curve, Figure 3D, left panel), with discern-
ible minima at 222nm and 208nm in the far-UV CD
spectra characteristic of a-helical conformation (40,41).
CarS1 produced similar eﬀects in the far-UV CD spectra
of P02 (not shown). On the other hand, the presence of
CarS1 caused no signiﬁcant change in the far-UV CD
spectrum of native CarANt, whose helices, notably a2,
are stably formed (Figure 3D, right panel). CarS aﬀected
the far-UV CD of P01 and CarANt in a manner similar to
CarS1.
ITC data conﬁrmed that P01 and P02 bind to CarS1 or
CarS (but not to F77A or D52A/D53A CarS*). Binding
occurred with a 1:1 stoichiometry and high aﬃnity (KD in
the nM range), and was driven by favorable enthalpy
(H), whose temperature dependence yielded a heat
capacity change on binding (CP)o f 0.57
kcalmol
 1K
 1, consistent with a net burial of
solvent-accessible surface (Figure 3E; Table 1). KD for
P01 was 2- to 3-fold lower than for P02. This suggests
small, if any, contributions to binding from the P-rich
segment C-terminal to a2 in P01. Thus, a peptide (P03)
corresponding to this segment alone did not bind to CarS1
or CarS under similar conditions (Table 1). Both P01 and
P02 bind with lower aﬃnities than CarANt (whose KD is
over an order of magnitude lower). This likely reﬂects the
energetic cost of inducing a-helix formation in the
peptides on binding to CarS/CarS1, in contrast to the
stably folded a2 in CarANt (41,42), although it cannot
be ruled out that some interactions of CarANt with
Table 1. ITC data for the binding of CarS and CarS1 to CarANt or a2 peptides
a
CarS/CarS1 CarANt/peptide Temperature ( C) N H (kcalmol
 1) KD (nM)
CarS CarANt 25 0.94±0.01  9.24±0.02 12±3
CarS P01 25 0.93±0.03  11.69±0.30 150±40
CarS P02 25 1.07±0.01  12.03±0.22 300±50
CarS CHP01 25 0.91±0.01  7.15±0.17 690±140
CarS1
b P01 25 0.92±0.02  8.46±0.13 150±18
CarS1
b P01 20 0.93±0.01  5.70±0.05 175±19
CarS1
b P01 30 0.89±0.01  10.88±0.07 200±17
CarS1
b P01 35 0.89±0.01  14.39±0.11 270±22
CarS1 P02 25 0.97±0.02  7.60±0.10 490±90
aHeat changes were negligible or undetected for the following titrations: (i) CarANt or P01 with CarS(F77A) or CarS(D52A/D53A); (ii) P03 with
CarS or CarS1; (iii) TtP01 with CarS (for details on peptides P01, P02, P03, CHP01 and TtP01, see Figures 3A and 4A, and text).
bTemperature dependence of H for these titrations was used to estimate CP= 0.57±0.03kcalmol
 1K
 1. Values represent the average of at
least two independent titrations.
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indicate that P01 and P02 do interact tightly with CarS1
(or CarS), and do so as a-helices whose formation is
enhanced upon binding. Thus, CarA a2 alone is suﬃcient
for tight binding to CarS.
CarS binds the CarH DNA recognition helix
CarS, as noted earlier, also binds to the CarH N-terminal
DNA-binding domain, CarHNt (15). Furthermore, the
latter has a segment closely matching CarANt a2 and an
adjacent, less-conserved C-terminal stretch with two P
Figure 3. CarA a2 peptides interact with CarS or CarS1. (A) CarA a2 peptide sequences. The a2 segment is underlined in red and the two P in
black. P03 has a non-native W for concentration determination. (B) Methyl
1H-
13C HSQC crosspeaks of
13C,
15N-labeled H6CarS1 perturbed by a
1.5-fold excess of unlabeled P02. Details are as in Figure 1C. (C) CarS1 sequence indicating residues for which the
1H-
15N HSQC crosspeaks shifted
[shaded black; d(
1H,
15N 0.05ppm)] or disappeared (shaded gray) on titrating with P01 or P02. Other residues were unchanged or could not be
assigned. An asterisk below indicates interaction with CarA from mutagenesis data. (D) Far-UV CD spectra of P01 and CarANt in the absence and
presence of CarS1. Black curves: P01 (18mM) or CarANt (11mM) alone; red curves: molar ellipticity diﬀerence between the spectrum of CarS1 mixed
with P01 or CarANt (1:1 molar ratio) and that of CarS1 alone. (E) ITC of 20mM P01 or P02 with CarS1 (216mM) at 25 C. The heat change with
each injection (top panels) and the corresponding integrated heat normalized and corrected for the heat of dilution versus molar ratio (bottom
panels) are shown. The line is a best ﬁt of data to a single-site binding model for the parameters in Table 1.
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CarANt, R42 in CarHNt is critical for operator-binding
(15). A crucial determinant for CarS-binding is R24 in
CarANt (10), and mutating the corresponding R27 in
CarHNt to A also destabilizes complex formation with
CarS, as monitored by analytical gel ﬁltration
(Figure 4B). Thus, CarHNt conserves at least two key
CarANt residues involved in binding to operator and
CarS, respectively. We therefore examined using ITC if
CHP01, a CarHNt peptide equivalent to P01, also binds
to CarS with high aﬃnity. We found that CHP01 can
indeed bind tightly to CarS, but with a KD somewhat
higher than for P01 (Figure 4C and Table 1). Thus, the
CarHNt segment equivalent to CarANt a2 is also suﬃ-
cient for interaction with CarS.
A segment similar to CarA/CarH a2 is conserved in
several proteins of unknown functions with a CarA/
CarH-like domain architecture that have been identiﬁed
from bacterial genome data (15). The N-terminal region of
one such protein (from Thermus thermophilus) is shown in
Figure 4A. A peptide derived from the latter, TtP01, the
counterpart of P01 or CHP01, did not bind CarS when
monitored by ITC (Table 1). TtP01 does not conserve
CarANt R15 nor A21 (in CarHNt, these are R18 and
A24, respectively; Figure 4A). Since CarS-binding was
not impaired on mutating CarA R15 to A (10), the A21
Figure 4. Analysis of CarS interactions with CarHNt. (A) Sequence alignment of CarANt, CarHNt and TtCANt, the N-terminal domain of the
T. thermophilus CarA/CarH-like protein (NCBI accession codes: CAA79964, CAA79965 and NP_967879, respectively). Identical residues are shaded
black and marked with an asterisk in the line corresponding to ‘consensus’; similar residues are shaded gray. Shown boxed are the a2 segment (solid
lines) and the P-rich part C-terminal to a2 (dotted lines). Black arrows indicate CarA a2 residues contacting CarS from NMR or site-directed
mutagenesis data (10), and the green arrow that this residue in CarH is also implicated in CarS-binding, as inferred from site-directed mutagenesis
(B). The line at the bottom spans the stretch corresponding to peptides P01 in CarANt, CHP01 in CarHNt and TtP01 in TtCANt. Red lines point to
residues conserved in P01 and CHP01, but not in TtP01. (B) Elution proﬁles oﬀ a Superdex200 analytical gel ﬁltration column for the pure proteins
(bottom) or mixtures (top) as labeled, with Mr (in kDa) for each peak maximum marked on top. The top panel shows that CarS forms a 1:1 complex
(Mr&35kDa) with CarHNt (red), but not its R27A mutant (blue). Yeast two-hybrid analysis conﬁrmed the lack of interaction with CarS of the
R27A variant of whole CarH (not shown). (C) ITC of 20mM CHP01 titrated with 216mM CarS shown as in Figure 3E. The line is the best ﬁt of data
to a single-site binding model for the parameters in Table 1.
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did not bind CarS.
Model of the CarS1–CarANt complex and comparison
with that of operator–CarANt
A structural model of the CarS1–CarANt complex was
generated using HADDOCK as described in ‘Materials
and Methods’ section (Figure 5A). In this model,
CarANt docked via a2 in a unique orientation on
CarS1, the resulting interface burying  1322A ˚ 2 of
surface area. The free protein structures were largely
maintained in the complex, except for a ﬂexible segment
in the CarS1 b2–b3 loop (residues 50–60), whose exclusion
in a superposition of the free and the bound structures
reduced backbone RMSD from 2.5 to 1.5A ˚ . Thus, the
pocket for housing a2 appears to pre-exist in CarS1. The
shape and electrostatic complementarity of the contact
surfaces are apparent in Figure 5A, where a positively
charged ridge on CarA a2 nestles into a hydrophobic
pocket with a negatively charged rim in CarS1. The im-
portance of electrostatic eﬀects is evident from the de-
pendence of stable complex formation on ionic strength
(Supplementary Figure S4). Besides L63, L75 and F77,
whose functional importance has been demonstrated
here, the model implicates T34 and P62 of CarS1, and
I140, A170 and A210 of CarA a2 (prime indicates CarA
residue) in hydrophobic contacts at the interface. I140
and A210 are conserved as V and A, respectively, but
A170 is E in the equivalent CarH a2 segment, which
binds to CarS (Table 1 and Figure 4). That A210,
conserved in both CarA and CarH, is important is
reinforced by the observation that TtP01, where Q
replaces A210, does not bind to CarS. The docking
suggests salt-bridge interactions involving charged
residues R240, R250, D53 and E79, whose functional sig-
niﬁcance was established by site-directed mutagenesis. In
the model, R200 participates in charge interactions with
E79 and D32, and in cation–p interactions with F77.
The ﬁnding that mutating R200 to A produced no
apparent impairment in interactions with CarS (10) may
be due to this change being accompanied by compensatory
interactions and/or local structural readjustments.
Determinants necessary for tight binding to CarS1 as
well as to operator DNA reside in the basic a2 (theoretical
pI=10.7). Hence, we compared a2 contacts with CarS1
versus those with DNA (Figure 6). CarANt conserves the
winged-helix topology and most of the crucial DNA
contacts of MerR-family proteins and, like the latter,
operator-binding bends the DNA about the central di-
nucleotide (10). In our model of the complex, a2
occupies the major groove of this bent operator half-site,
with its axis nearly perpendicular to that of DNA and
burying 1150A ˚ 2 of surface area at the interface. The
operator and CarS1 surfaces that contact a2 are both
polar and similar in size, and the relative locations and
trajectories of negatively charged groups involved in the
interactions are comparable (Figure 6). This is consistent
with a critical role for electrostatic interactions in both
cases, with complex formation being salt-sensitive and
crucially dependent on speciﬁc charged residues. Thus,
three out of the four R in a2 determine operator binding
and their mutation relieves carB repression, while the
fourth (R240) has a marginal though observable eﬀect
(10). At least two of these (R240 and R250) are also
Figure 5. Model of the CarS1–CarANt complex. (A) Electrostatic surface and ribbon representations of CarS1–CarANt complex illustrating charge
and shape complementarity of the interacting surfaces. In the ribbon model, side chains at the interface are depicted as sticks in red (E or D) or pink
(uncharged residues) for CarS1, and dark (R) or pale blue (uncharged) for CarANt. Dotted lines are possible H-bonds. (B) CarS1 sequence with
residues interacting with those in CarANt (boxed) linked by double-headed arrows and colored as in (A).
5236 Nucleic Acids Research, 2010,Vol.38, No. 15critical in the binding to CarS1, as are speciﬁc D and E
residues in the latter.
DISCUSSION
CarS and SH3 domains
This study provides a high-resolution structural descrip-
tion of the CarS antirepressor and its mode of action in
activating a photo-inducible transcriptional switch. The
structure reveals a b-barrel fold akin to that in SH3
domains. However, it diverges from the typical SH3
domain fold in the lengths and conformations of the con-
necting loops, notably those equivalent to the n-Src and
RT loops, the location of a 310 helix, and the presence of a
long N-terminal extension. Also, although the molecular
activity of CarS is in protein–protein interactions, like
SH3 domains, CarS is a novel variant of this domain
superfamily in its ligand binding mode and speciﬁcity, as
discussed next.
SH3 domains typically bind to P-rich domains, whose
speciﬁcity and aﬃnity is often increased by basic R or K
engaging acidic E or D of the SH3 domain (16,18). P-rich
domains bind as a poly-proline type II (PPII) helix to two
hydrophobic grooves and a pocket formed by the RT and
n-Src loops in the SH3 domain, the aﬃnities for the
enthalpically-driven association characterized by KD of
usually 1–200mM, and CP of  0.15 to  0.35
kcalmol
 1K
 1 (16,18,43). Besides the conventional union
to a P-rich domain, the more exceptional Pex13p SH3
Figure 6. Comparison of CarA a2 contacting CarS1 and DNA. (A) Top: CarS1-CarNt complex as ribbon models (left and centre) or with CarS1 in
electrostatic surface representation (right). Charged side chains at the interface are shown as sticks and CarANt a2 is in purple. Bottom: CarANt in
complex with the distorted pI half-site of operator DNA (10). CarANt is shown as in the models above. DNA is represented as a stick model with
one strand in black, the other in gray, and phosphates as red spheres (left and centre), or by the electrostatic surface (right). (B) Close-up view of the
CarANt a2-binding site in operator DNA (left) and in CarS1 (right). Charged side chains at the interface are displayed as sticks with a2 oriented as
in the ribbon models on the left in (A).
Nucleic Acids Research, 2010,Vol.38, No. 15 5237domain and p67
phox use a distinct surface to simultaneous-
ly bind an a-helix or a helix-turn-helix, respectively
(44,45). Thus, the p67
phox SH3 domain binds to both a
P-rich domain and a contiguous C-terminal
helix-turn-helix with an aﬃnity (KD=24nM) far greater
than to each of the two segments separately
(KD=10–20mM). Some SH3 domains employ the same
hydrophobic groove to bind not only canonical P-rich
domains but also ubiquitin or ubiquitin-like domains
with comparable aﬃnities (46,47). The few ‘SH3
domain-like’ units known in bacteria are modules of
larger proteins engaged in oligomerization via surfaces
distinct from those in eukaryotic SH3 domains (38,48),
and only for that in the DtxR repressor is there evidence
of binding to a P-rich motif (49).
For speciﬁc, high-aﬃnity interaction with CarS the
operator DNA recognition helix a2 in CarA or CarH is
suﬃcient, and a P-rich segment C-terminal to a2 contrib-
utes little, if at all. The CarS interaction surface, encom-
passing residues in the b2–b3 loop and the b4–b5 stretch,
also diﬀers from the pockets used by other SH3 domains
to bind P-rich domains, ubiquitin, or a-helices. Tight as-
sociation is achieved by hydrophobic contacts of large
non-polar side chains and from interactions involving
charged R in the basic a2 and D/E in the acidic CarS.
The a-helical conformation, as already existing in native
CarA, is required for binding to CarS. Even isolated
a2 peptides with low helix contents bind as an a-helix
and, despite the energetic cost for this induced
folding, have aﬃnities (KD=150–500nM) and
CP ( 0.57kcalmol
 1K
 1) that exceed those reported
for typical SH3 domains and their ligands. Our results
thus indicate an unprecedented mode for protein–protein
recognition by an SH3 domain-like fold that is employed
in transcriptional regulation.
CarS acts as an operator DNA mimic
A way to dismantle operator–repressor complexes is, as
noted earlier, non-covalent union to an antirepressor.
Direct targeting of critical DNA-recognition elements to
sequester them and neutralize repressor activity is the
strategy resorted to by the CarS antirepressor. CarA
binds in a cooperative, stepwise manner to its bipartite
operator (Figure 7) (14). Disrupting the pre-bound
CarA–DNA complex would be determined by its dissoci-
ation kinetics, and by CarS trapping the freed CarA so as
to hinder it from binding again to operator. This would be
favored if the union of CarS and CarA is tight enough to
compete eﬀectively against operator, and if CarS amounts
far exceed the single operator site per cell. The aﬃnity for
operator remains to be precisely quantiﬁed, but available
in vitro data suggest that CarANt binds to the operator
pI site with KD in the 100–200nM range (10). Aﬃnity for
the pII site would then be much lower; yet mutating it is
suﬃcient to abolish repression by CarA (14). That CarS
binds CarANt with high aﬃnity is evident from the KD
( 10nM) estimated in this study, while high intracellular
CarS levels are ensured by its light-induced expression
(50). Together, these rationalize how CarS can compete
eﬀectively against operator to trap the CarA DNA-
binding domain and enable antirepression (Figure 7).
Our ﬁnding that CarS binds tightly to the CarA a2
peptide emphasizes that the speciﬁc targeting and seques-
tering of a2, the critical DNA-recognition element, under-
lies antirepression by CarS. In directly targeting several
residues in a2 that also contact DNA, and in its highly
acidic nature and use of negatively charged residues for
key interactions, CarS acts as an operator DNA mimic.
While its overall negative charge may facilitate complex
formation, the shape and charge complementarity already
sculpted on the SH3 domain-like scaﬀold of CarS under-
pins its ability to bind a2 with high speciﬁcity and aﬃnity.
By contrast, operator-binding via a2 must incur an add-
itional energetic cost as it is accompanied by DNA distor-
tion. Indeed, it is the bent or distorted conformation of the
speciﬁc DNA site rather than the normal B form that is
imitated by protein mimics of DNA to sequester their
target DNA-binding proteins (51,52). The small number
of reported protein DNA mimics are typically very acidic
(theoretical pI: 3.8–5.5) like CarS1 (pI=4.1) or CarS
(pI=4.8), and their targets include restriction enzymes
(53,54), DNA repair enzymes (55,56), DNA gyrase (57),
Figure 7. Model for the control of carB expression by CarA/CarH-CarS repressor–antirepressor pairs highlighting known details of the domains,
their structures and interactions. CarA and CarH dimerize via their C-terminal B12-binding domains (pink oval) and bind to the bipartite operator
(orange) via their N-terminal, MerR-type winged-helix domain (green triangle; the purple line represents the DNA recognition helix a2) to repress
carB in the dark. The SH3 domain-like CarS (cyan) produced in the light binds tightly to a2 to sequester CarA and CarH, prevent their binding to
operator DNA and activate carB expression.
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In transcription regulation, the one structurally
well-characterized example of a DNA mimic is the
N-terminal subdomain (TAND1) of eukaryotic
TAF||230, which binds to TBP, the TATA-binding
protein (60). TBP binds DNA using an extended,
concave surface constituted by a ten-stranded, antiparallel
b-sheet. TAND1 is intrinsically disordered. To insert itself
into the concave TBP DNA-binding surface to shut down
transcription, TAND1 adopts a deﬁned structure that pre-
cisely imitates the bend and distortion of the partially
unwound minor groove of the TATA-box target site. By
comparison, the stably folded CarS mirrors the distorted
major groove of the operator to lock on to CarA (or
CarH) a2, a much smaller target, and turn on
transcription.
Until recently, CarA and CarH were the only transcrip-
tional regulators known with a MerR-type DNA-binding
domain linked to a vitamin B12-binding domain. Genome
data now reveal that several other bacteria also contain
proteins with this domain architecture, but whose func-
tions are unknown (15). Interestingly, although one of
the most highly conserved regions in these is that corres-
ponding to CarA/CarH a2, BLAST analysis indicates that
a protein similar to CarS in sequence does not exist in any
of these bacteria (except Stigmatella aurantiaca,a
myxobacterium very closely related to M. xanthus;
Supplementary Figure S5). The question therefore arises
as to how the activities of CarA/CarH-like proteins in
these other bacteria are modulated, and whether it
involves factors that, despite no overall sequence similar-
ity, resemble CarS functionally and possibly structurally.
Future work addressing these issues, as well as the design
of proteins tailored to target speciﬁc DNA-binding
proteins, can clearly draw upon the structural and mech-
anistic details emerging from our studies on CarA, CarH
and CarS function in M. xanthus.
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